A network that brings together the biotech communities in Scandinavian and Baltic states has been awarded a grant of €1 million from the European Union this week—cash the alliance of fledgling industries hopes will bolster their efforts to compete on the global stage.

The network, dubbed ScanBalt, said that it would use the money to analyze the activities of all its members and identify core competencies as a first step in improving the network's effectiveness and efficiency.

The ScanBalt network is a single central structure that holds together the multitude of national and binational biotech networks that already exist in the region. It was founded in 2001. The ScanBalt region includes parts or all of 11 countries, encompassing 67 universities and around 900 biotech and life science companies: Denmark, Estonia, Finland, Iceland, Latvia, Lithuania, Norway, Sweden, Poland, the northern part of Germany, and northwest Russia.

The European Union...

Interested in reading more?

Become a Member of

Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member?